<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Lindsay Rosenwald Biography &#124; Life Facts Of Lindsay Rosenwald</title>
	<atom:link href="http://www.lindsay-rosenwald.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.lindsay-rosenwald.net</link>
	<description>Biography Lindsay Rosenwald</description>
	<lastBuildDate>Fri, 09 Sep 2011 14:13:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>OpusPoint Partners: Successfully Melding the Worlds of Finance and Biotechnology</title>
		<link>http://www.lindsay-rosenwald.net/opuspoint-partners-successfully-melding-worlds-finance-biotechnology-32/</link>
		<comments>http://www.lindsay-rosenwald.net/opuspoint-partners-successfully-melding-worlds-finance-biotechnology-32/#comments</comments>
		<pubDate>Fri, 09 Sep 2011 14:13:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[LindsayRosenwald]]></category>
		<category><![CDATA[biotechnology sphere]]></category>
		<category><![CDATA[Orion Fund]]></category>

		<guid isPermaLink="false">http://www.lindsay-rosenwald.net/?p=32</guid>
		<description><![CDATA[OpusPoint Partners through the guidance of its co-founders, Michael Weiss and Lindsay Rosenwald, M.D., are indisputably bringing about transformational biotechnology and life science companies to the forefront. The company’s investment in and mentoring of these budding biotech companies is the first step in making new discoveries that will make waves in the healthcare sector and [...]]]></description>
		<wfw:commentRss>http://www.lindsay-rosenwald.net/opuspoint-partners-successfully-melding-worlds-finance-biotechnology-32/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Step Ahead By Lindsay Rosenwald In Field Of LifeScience &amp; Healthcare Investment</title>
		<link>http://www.lindsay-rosenwald.net/step-lindsay-rosenwald-field-lifescience-healthcare-investment-26/</link>
		<comments>http://www.lindsay-rosenwald.net/step-lindsay-rosenwald-field-lifescience-healthcare-investment-26/#comments</comments>
		<pubDate>Wed, 08 Jun 2011 15:02:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[LindsayRosenwald]]></category>
		<category><![CDATA[lindsay rosenwald]]></category>
		<category><![CDATA[Lindsay Rosenwald Healthcare Investment]]></category>
		<category><![CDATA[Lindsay Rosenwald Lifescience investment]]></category>

		<guid isPermaLink="false">http://www.lindsay-rosenwald.net/?p=26</guid>
		<description><![CDATA[OpusPoint Partners: Investing in the Future ofHealthcare and Life Sciences &#160; At OpusPoint Partners,we have a vision for an amazing future for the life science and healthcare industry. We believe in that vision so strongly that we are investingmoney and time to advance life sciences and biotechnology. We also believe in a strong, healthy future [...]]]></description>
		<wfw:commentRss>http://www.lindsay-rosenwald.net/step-lindsay-rosenwald-field-lifescience-healthcare-investment-26/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lindsay Rosenwald Investing in the Future ofLife Sciences and Healthcare</title>
		<link>http://www.lindsay-rosenwald.net/lindsay-rosenwald-investing-future-oflife-sciences-healthcare-24/</link>
		<comments>http://www.lindsay-rosenwald.net/lindsay-rosenwald-investing-future-oflife-sciences-healthcare-24/#comments</comments>
		<pubDate>Wed, 08 Jun 2011 14:57:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[LindsayRosenwald]]></category>
		<category><![CDATA[lindsay rosenwald]]></category>
		<category><![CDATA[Lindsay Rosenwald Firm]]></category>
		<category><![CDATA[Lindsay Rosenwald Investment Firm]]></category>

		<guid isPermaLink="false">http://www.lindsay-rosenwald.net/?p=24</guid>
		<description><![CDATA[OpusPoint Partners is an innovative new company with a unique vision for the future of the life science and healthcare industry. That vision includes some cutting edge technologies but also some forward thinking business philosophies. As with alllofty visionssuchas this, itwill take immense commitment from quality entrepreneurs to accomplish. Michael S. Weiss and Dr. Lindsay [...]]]></description>
		<wfw:commentRss>http://www.lindsay-rosenwald.net/lindsay-rosenwald-investing-future-oflife-sciences-healthcare-24/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>J&amp;J’s Abiraterone Acetate Demonstrated Significant Improvement in Patients with Metastatic Advanced Prostate Cancer</title>
		<link>http://www.lindsay-rosenwald.net/lindsayrosenwald-demonstrated-significant-improvement-21/</link>
		<comments>http://www.lindsay-rosenwald.net/lindsayrosenwald-demonstrated-significant-improvement-21/#comments</comments>
		<pubDate>Fri, 01 Apr 2011 04:27:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Lindsay Rosenwald Achievements]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[lindsay rosenwald]]></category>
		<category><![CDATA[lindsay rosenwald discovery]]></category>
		<category><![CDATA[Lindsay Rosenwald significant improvements]]></category>

		<guid isPermaLink="false">http://www.lindsay-rosenwald.net/?p=21</guid>
		<description><![CDATA[Based on the results observed in patients, who received abiraterone acetate plus prednisone/prednisolone, Johnson &#38; Johnson plans to file marketing applications for a promising discovery, abiraterone acetate, which significantly increases overall survival in patients with advanced prostate cancer progressed after chemotherapy. Randomized, placebo-controlled Phase III study, COU-AA-301, shows that patients receiving abiraterone plus low doses [...]]]></description>
		<wfw:commentRss>http://www.lindsay-rosenwald.net/lindsayrosenwald-demonstrated-significant-improvement-21/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lindsay Rosenwald&#8217;s Abilities</title>
		<link>http://www.lindsay-rosenwald.net/lindsay-rosenwalds-abilities-6/</link>
		<comments>http://www.lindsay-rosenwald.net/lindsay-rosenwalds-abilities-6/#comments</comments>
		<pubDate>Thu, 08 Apr 2010 06:47:22 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[About Lindsay]]></category>
		<category><![CDATA[lindsay]]></category>
		<category><![CDATA[lindsay rosenwald]]></category>
		<category><![CDATA[Lindsay Rosenwald Biography]]></category>
		<category><![CDATA[Lindsay Rosenwald Biotechnology achievements]]></category>
		<category><![CDATA[lindsay rosenwald facts]]></category>
		<category><![CDATA[lindsay Rosenwald Life Facts]]></category>
		<category><![CDATA[Lindsay Rosenwald’s major accomplishments]]></category>
		<category><![CDATA[previous employees]]></category>
		<category><![CDATA[rosenwald]]></category>

		<guid isPermaLink="false">http://www.lindsay-rosenwald.net/?p=6</guid>
		<description><![CDATA[It was in the fall of 1995 when I answered the New York Time&#8217;s advertisement that stated that an up and coming venture capital firm was looking for a CEO to assist its specialty medical centers. I was escorted into Dr. Lindsay Rosenwald&#8217;s office for the interview, where I then sat for about six hours, [...]]]></description>
		<wfw:commentRss>http://www.lindsay-rosenwald.net/lindsay-rosenwalds-abilities-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

